Product
VitaSIRO solo™ SARS-CoV-2/Flu/RSV Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.
Molecular Assays
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
For professionals
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
For professionals
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
For professionals
Tests
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
For professionals
Article
Research record from Int J Mol Sci, 2026-05-14. PMID 42196372.
Article
Research record from Vaccines (Basel), 2026-09-15. PMID 42797632.
Article
Research record from Clin Microbiol Infect, 2026-03-27. PMID 41905558.
Article
Research record from Infect Dis Ther, 2026-04-04. PMID 41934527.
Article
Research record from Diagnostics (Basel), 2026-04-20. PMID 42072850.
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgA antibodies against SARS-CoV-2 using the S1 domain of the spike protein.
For professionals
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
For professionals